BCL11A and breast carcinoma: Based on this, the human TNBC cell line MDA-MB-231 was chosen due to strong expression of BCL11A and CHD8, and the luminal breast cancer cell line MCF-7 was selected as a control due to expression of CHD8 but no BCL11A expression.